person

Anne-Sophie G.

Country
France
Department
Service de Pneumologie

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
15
Sites with multiple studies

Has run more than one trial at 15 of 42 partner sites.

Specializations

Pulmonary Disease Management

This investigator specializes in treating complex interstitial lung diseases (ILD), with particular emphasis on progressive forms of pulmonary conditions. Their research extends to innovative therapeutic approaches for managing chronic respiratory disorders.

  • Progressive ILD
  • Inflammatory Lung Conditions
  • Idiopathic Pulmonary Fibrosis

Their expertise encompasses both inflammatory and fibrotic lung pathologies, focusing on therapeutic interventions for progressive respiratory conditions.

Advanced Therapeutic Applications

The investigator explores targeted therapeutic approaches using immunomodulatory treatments and antifibrotic agents. Their work involves evaluating novel combination therapies and treatment strategies for pulmonary disorders.

  • Rituximab Applications
  • Antifibrotic Therapy
  • Combination Treatment Strategies

Their research includes assessment of both established and innovative therapeutic agents in the treatment of progressive lung diseases.

Clinical Assessment Methods

The investigator focuses on evaluating treatment efficacy through pulmonary function metrics and systematic clinical assessments. Their approach includes monitoring disease progression and treatment response.

  • Lung Function Assessment
  • Disease Progression Monitoring
  • Treatment Response Evaluation

Their work incorporates comprehensive evaluation methods to track therapeutic outcomes in respiratory conditions.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.